CALDER_PHARMACY_LIMITED - Accounts

CALDER PHARMACY LIMITED - Company Information

Print Friendly Version

Company Registration No. SC268645 (Scotland)

CALDER PHARMACY LIMITED

UNAUDITED ABBREVIATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2015

CALDER PHARMACY LIMITED

CONTENTS

Page

Abbreviated balance sheet

1 - 2

Notes to the abbreviated accounts

3 - 4

CALDER PHARMACY LIMITED

ABBREVIATED BALANCE SHEET

AS AT

31 AUGUST 2015

- 1 -

2015

2014

Notes

Fixed assets

Intangible assets

131,400

146,000

Tangible assets

8,360

9,835

Investments

8,000

147,760

163,835

Current assets

Stocks

17,245

17,907

Debtors

291,484

290,975

Cash at bank and in hand

51,829

34,453

360,558

343,335

Creditors: amounts falling due within one year

(55,708)

(48,646)

Net current assets

304,850

294,689

Total assets less current liabilities

452,610

458,524

Creditors: amounts falling due after more than one year

(84,625)

(89,478)

Provisions for liabilities

(1,361)

(1,587)

366,624

367,459

Capital and reserves

Called up share capital

1,000

Profit and loss account

365,624

366,459

Shareholders' funds

366,624

367,459

CALDER PHARMACY LIMITED

ABBREVIATED BALANCE SHEET (CONTINUED)

AS AT

31 AUGUST 2015

- 2 -

For the financial year ended 31 August 2015 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These abbreviated financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

Approved by the Board for issue on 22 March 2016

Mr Charles Shanks

Director

Company Registration No. SC268645

CALDER PHARMACY LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS

FOR THE YEAR ENDED 31 AUGUST 2015

- 3 -

Accounting policies

1.1

Accounting convention

The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).

1.2

Compliance with accounting standards

The financial statements are prepared in accordance with applicable United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which have been applied consistently (except as otherwise stated).

1.3

Turnover

Turnover represents amounts receivable for goods and services net of VAT.

1.4

Goodwill

Goodwill, being the amount paid in connection with the acquisition of the business in 2004, is being amortised evenly over its useful life of twenty years.

1.5

Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Fixtures, fittings & equipment

15% on reducing balance

1.6

Investments

Fixed asset investments are held at net book value.

1.7

Stock

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

1.8

Pensions

The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are charged to the profit and loss account in the year they are payable.

1.9

Deferred taxation

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the balance sheet date.

A net deferred tax asset is regarded as recoverable and therefore recognised only when, on the basis of all available evidence, it can be regarded as more likely than not that there will be suitable taxable profits against which to recover carried forward tax losses and from which the future reversal of underlying timing differences can be deducted.

Deferred tax is measured at the average tax rates that are expected to apply in the periods in which the timing differences are expected to reverse, based on the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. Deferred tax is measured on a non-discounted basis.

CALDER PHARMACY LIMITED

NOTES TO THE ABBREVIATED ACCOUNTS (CONTINUED)

FOR THE YEAR ENDED 31 AUGUST 2015

- 4 -

Fixed assets

Intangible assets

Tangible assets

Investments

Total

Cost

At 1 September 2014 & at 31 August 2015

292,000

28,739

8,000

328,739

Depreciation

At 1 September 2014

146,000

18,904

164,904

Charge for the year

14,600

1,475

16,075

At 31 August 2015

160,600

20,379

180,979

Net book value

At 31 August 2015

131,400

8,360

8,000

147,760

At 31 August 2014

146,000

9,835

8,000

163,835

The unlisted investments is made up of the following investments:

500 £1 Ordinary Shares in Albapharm which are valued at £500, and 20 Ordinary Shares in SHC Pharmacy Limited which are valued at £7,500.

Debtors

Debtors include an amount of £183,000 (2014 - £200,000) which is due after more than one year.

Share capital

2015

2014

Allotted, called up and fully paid

1,000 Ordinary Shares of £1 each

1,000

Transactions with directors

Included in other debtors is a balance owed by Mr Charles Shanks of £193,183 (2014: £203,335). Interest at the average official rate was charged.